Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:24:31 EDT Sat 21 Jun 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:AGEN - AGENUS INC - https://agenusbio.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AGEN - Q1.04.70·4.820.44.78+0.316.91,477.96,7984,3734.57  4.98  4.5018.74  1.3819:49:21Jun 1715 min RT 2¢

Recent Trades - Last 10 of 4373
Time ETExPriceChangeVolume
19:49:21Q4.820.3530
19:39:57Q4.700.2327
19:04:17Q4.700.234
18:45:32Q4.600.1311
18:29:48Q4.810.345
17:41:37Q4.600.133
17:29:47Q4.810.34100
17:13:12Q4.600.134,500
17:13:12Q4.600.137,400
17:11:56Q4.600.134

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-17 07:30U:AGENNews ReleaseAgenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology
2025-06-10 13:30U:AGENNews ReleaseAgenus Announces Virtual Annual Shareholders Meeting
2025-06-03 07:00U:AGENNews ReleaseAgenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus' Biologics Manufacturing in the US
2025-05-30 07:30U:AGENNews ReleaseAgenus Presents New Data at ASCO Highlighting Botensilimab's Immune Activation in MSS Colorectal Cancer
2025-05-15 10:40U:AGENNews ReleaseAgenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025
2025-05-12 07:30U:AGENNews ReleaseAgenus Reports Q1 2025 Financial Results and Key Business Updates
2025-05-12 07:20U:AGENNews ReleaseRenowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer
2025-04-29 07:30U:AGENNews ReleaseAgenus to Provide Corporate Update and First Quarter 2025 Financial Report
2025-04-28 15:30U:AGENNews ReleaseAgenus' BOT/BAL Neoadjuvant Pan-Cancer Data from the NEOASIS Study Presented in an Oral Session at AACR
2025-04-25 13:05U:AGENNews ReleaseAgenus' BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025
2025-04-23 12:05U:AGENNews ReleaseAgenus Announces Botensilimab and Balstilimab Presentations at ASCO 2025
2025-03-25 16:40U:AGENNews ReleaseAgenus to Present New BOT/BAL Data in Two Presentations at AACR 2025
2025-03-19 07:30U:AGENNews ReleaseAgenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation
2025-03-11 07:30U:AGENNews ReleaseAgenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program
2025-02-26 16:48U:AGENNews ReleaseAgenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications
2025-02-25 14:30U:AGENNews ReleaseAgenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference
2025-02-25 08:26U:AGENNews ReleaseAgenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report
2025-02-24 08:33U:AGENNews ReleaseAgenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting
2025-02-12 10:00U:AGENNews ReleaseCORRECTING and REPLACING Agenus' BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting